Exercise News and Research

Latest Exercise News and Research

New drug improves glycaemic control with minimum risk of hypoglycemia in type 2 diabetics

TAK-875, a new treatment for type 2 diabetes, improves blood sugar control and is equally effective as glimepiride, but has a significantly lower risk of creating a dangerous drop in blood sugar, called hypoglycemia, according to a new study.

27 Feb 2012

Gallup-Healthways WBI data shows decline in the U.S. obesity rates

Adult obesity in America has plateaued and may be slowly declining, according to data from The Gallup-Healthways Well-Being Index (WBI) presented today at the Population Health and Care Coordination Colloquium in Philadelphia. The obesity rate in America fell in 2011 to 26.1 percent, from 26.6 percent in 2010 and 26.5 percent in 2009.

27 Feb 2012

Statins may reduce risk of depression in patients with heart disease

Patients with heart disease who took cholesterol-lowering statins were significantly less likely to develop depression than those who did not, in a study by Mary Whooley, MD, a physician at the San Francisco VA Medical Center and a professor of medicine at the University of California, San Francisco.

27 Feb 2012

The Lancet publishes Takeda's TAK-875 Phase 2 data on type 2 diabetes

Phase 2 clinical data of an investigational type 2 diabetes therapy, TAK-875 of Takeda Pharmaceutical Company Limited, were published online first in The Lancet.

27 Feb 2012

Citrus fruits may keep stroke at bay for women

In the study published last Thursday in Stroke, a journal of the American Heart Association, researchers analyzed the flavonoid intake of 69,622 women from the U.S.-based Nurses’ Health Study, which has followed nurses since 1976 to assess risk factors for cardiovascular disease and cancer. The total flavonoid intake of the 69,622 women was calculated after they completed food intake questionnaires collected every four years using a U.S. Department of Agriculture database. They found that during 14 years of follow up surveys beginning in 1990, 1,803 incidents of strokes were confirmed from the women.

26 Feb 2012

FDA panel votes in favor of earlier rejected anti-obesity drug Qnexa

Qnexa took a step closer to approval on Wednesday, when outside advisers to the U.S. Food and Drug Administration voted 20-to-2 in favor of approval. The panel also recommended the company conduct a study to scrutinize even more closely any risk of heart problems. That study may be required after the drug is approved. Should the FDA ask for further data on heart risks before any approval, it would delay Qnexa's launch further.

26 Feb 2012

Study strengthens statistical link between BPA and heart disease

Bisphenol A (BPA) is a controversial chemical widely used in the plastics industry. A new study followed people over a 10-year time period and shows that healthy people with higher urine concentrations of BPA were more likely to later develop heart disease.

24 Feb 2012

Radiation risk from Japan's nuclear disaster debris not a worry, but other aspects might be

The first anniversary is approaching of the March, 2011, earthquake and tsunami that devastated Fukushima, Japan, and later this year debris from that event should begin to wash up on U.S. shores - and one question many have asked is whether that will pose a radiation risk.

23 Feb 2012

Videotaped encounter evaluates medical students conveying bad news to 'standardized patients'

Researchers at Moffitt Cancer Center in Tampa, Fla., and the University of South Florida (USF) College of Medicine evaluated the experience of medical students who participated in videotaped sessions where they practiced conveying difficult news to "standardized patients" (SPs). The SPs role-played patients with a variety of cancers and who were receiving bad medical news.

23 Feb 2012

Experts to discuss current treatments for children with heart disease at Cardiology 2012

An international group of almost 1000 medical experts gathers this week to discuss the most current treatments for children with heart disease. Affecting about a million children born each year throughout the world, congenital heart disease is the most common birth defect. In its severe forms, it is also the leading cause of death from birth defects in infants.

23 Feb 2012

HPSO, CNA HealthPro collaborate to publish Physical Therapy Liability report

CNA HealthPro, a leader in the healthcare professional liability insurance industry, recently collaborated with Healthcare Providers Service Organization (HPSO) to publish a report focused on the risks encountered by physical therapists.

23 Feb 2012

DIRECT project to focus on stratification of patients with type 2 diabetes

Gathering experts from 21 European academic institutions and key players of the pharmaceutical industry, the DIRECT project (DIabetes REsearch for patient straTification) will focus on the stratification of patients with type 2 diabetes in order to develop personalized treatments, that would therefore be more efficient.

23 Feb 2012

Elevated levels of two TLRs can trigger heart disease and diabetes

UC Davis scientists have uncovered a key suspect in the destructive inflammation that underlies heart disease and diabetes. The new research shows elevated levels of a receptor present on leucocytes of the innate immune response in people at risk for these chronic diseases.

23 Feb 2012

Assessing family medical history helps spot patients at high risk of heart disease

A new study by researchers at The University of Nottingham has proved that assessing family medical history is a significant tool in helping GPs spot patients at high risk of heart disease and its widespread use could save lives.

23 Feb 2012

MannKind net loss for 2011 decreases to $160.8 million

MannKind Corporation today reported financial results for the fourth quarter and year ended December 31, 2011.

23 Feb 2012

Depomed, Santarus reach agreement to resolve GLUMETZA patent litigation with Lupin

Santarus, Inc. and Depomed, Inc. today announced that they have entered into a settlement agreement with Lupin Ltd. and its subsidiary, Lupin Pharmaceuticals, Inc., to resolve pending patent litigation involving GLUMETZA 1000 mg and 500 mg.

23 Feb 2012

Statins can reduce risk of depression

Researchers at Charité - Universitätsmedizin Berlin and the University of California San Francisco have studied the link between medication taken for cardiovascular disease and the development of depression. In their studies, scientists have determined that a particular class of medication, i.e. statins, can reduce the risk of developing depression.

22 Feb 2012

CMS unveils 2013 Medicare Advantage payment and policy guidelines

Federal officials said Friday that the trend toward relatively low premium charges and stable benefits will likely continue.

22 Feb 2012

Some diets and diet pills may cause further kidney damage in overweight adults

With 1 in 5 overweight Americans suffering from chronic kidney disease, Cleveland Clinic researchers analyzed the nutritional and lifestyle habits of overweight adults, finding that their methods included diets and diet pills that may cause further kidney damage.

22 Feb 2012

Parental exposure to PFOA may increase risk of obesity in their daughters

The levels of the environmental pollutant perfluorooctanoic acid (PFOA) that mothers had in their blood during pregnancy increased the risk of obesity in their daughters at 20 years of age.

22 Feb 2012